Invention Grant
- Patent Title: Benzodiazepine derivatives as CCK2/gastrin receptor antagonists
-
Application No.: US16382737Application Date: 2019-04-12
-
Publication No.: US10906884B2Publication Date: 2021-02-02
- Inventor: Malcolm James Boyce , Liv Thomsen , Donald Alan Gilbert , David Wood
- Applicant: Trio Medicines Ltd
- Applicant Address: GB Brighton
- Assignee: Trio Medicines Ltd
- Current Assignee: Trio Medicines Ltd
- Current Assignee Address: GB Brighton
- Agency: Lathrop GPM LLP
- Agent Brian C. Trinque
- Priority: GB1414116.2 20140808
- Main IPC: C07D401/04
- IPC: C07D401/04 ; A61P1/14
Abstract:
The invention relates to benzodiazepine derivatives of formula (A) useful as CCK2/gastrin receptor antagonists, their preparation and their use in the treatment or prevention of disorders associated with CCK2/gastrin receptors, disorders caused by or associated with hypergastrinaemia, and gastric acid-related disorders.
Public/Granted literature
- US20190233391A1 Benzodiazepine Derivatives As CCK2/Gastrin Receptor Antagonists Public/Granted day:2019-08-01
Information query
